Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Promoting Neuroplastic Changes of Patients With TBI

NCT: NCT06465290 · RECRUITING

NCT IDNCT06465290
StatusRECRUITING
Start Date2026-07-16
Completion2030-08-31
SponsorUniversity of Maryland, Baltimore (OTHER)
First posted
Last updated

Brief Summary

This project will develop a wearable rehabilitation robot suitable for in-bed acute stage rehabilitation. It involves robot-guided motor relearning, passive and active motor-sensory rehabilitation early in the acute stage post-TBI including patients who are paralyzed with no motor output. The early acute TBI rehabilitation device will be evaluated in this clinical trial.

Frequently Asked Questions

What is Promoting Neuroplastic Changes of Patients With TBI?

Promoting Neuroplastic Changes of Patients With TBI is a clinical trial registered under NCT06465290. Current status: RECRUITING.

What is the status of NCT06465290?

The current status of NCT06465290 (Promoting Neuroplastic Changes of Patients With TBI) is: RECRUITING.

When did Promoting Neuroplastic Changes of Patients With TBI start?

Promoting Neuroplastic Changes of Patients With TBI started on 2026-07-16.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.